Law ❯ Regulatory Compliance ❯ Securities Exchange Act

SEC Regulations

Rule 10b-5 False Statements

Plaintiff Firms Seek Lead Plaintiffs in Securities Suits Over Immutep’s TACTI‑004 Trial

Lawyers say Immutep concealed negative Phase III data that left investors who bought between March 24, 2025 and March 12, 2026 facing losses.

Investors File Suit After Immutep’s Phase III Lung Cancer Trial Is Stopped and ADRs Collapse

Plaintiff Firms Seek Lead Plaintiffs in Commvault Securities Suits

FS KKR Capital Sued in Securities Class Action as Firms Seek Lead Plaintiff

Law Firms Urge SES AI Investors to Join Securities Class Action Before June 26

Law Firms Court Gauzy Investors for Lead Role in Securities Suit as Feb. 6 Deadline Nears

James Hardie Investors Face Dec. 23 Lead‑Plaintiff Deadline in Securities Class Action

DeFi Technologies Faces Securities Class Action in New York as Law Firms Seek Lead Plaintiffs

Primo Brands Investors Pressed to Act as Securities Suits Target BlueTriton Merger Disclosures

Skye Bioscience Investors Pressed to Seek Lead Role in Securities Suit as Jan. 16 Deadline Nears